Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Irritable Bowel Syndrome With Constipation (IBS-C)
View Full LandscapeTarget Indication
Irritable Bowel Syndrome With Constipation (IBS-C)
Clinical Trial
NCT02316899Last updated: 12/24/2025
No patent data available. Pre-approval drugs may not have Orange Book listings.
Constella
Constella is indicated for the symptomatic treatment of moderate to severe irritable-bowel syndrome with constipation (IBS-C) in adults.
View on EMA